trending Market Intelligence /marketintelligence/en/news-insights/trending/8W3cPusXRM6Dbp9jAuJOpw2 content esgSubNav
In This List

Abbott extends tender offer deadline for Alere preferred stock

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Abbott extends tender offer deadline for Alere preferred stock

Abbott Laboratories extended its cash tender offer to acquire all outstanding series B convertible perpetual preferred stock of Alere Inc.

Abbott launched the offer to acquire Alere's preferred stock at $402 apiece, plus accrued but unpaid dividends, on July 17. The tender offer, originally set to expire Aug. 11, has been extended to Aug. 31. More than 90% of the issued and outstanding shares of Preferred Stock had been tendered as of Aug. 11.

The acquisition valued at $5.3 billion is not conditional on the completion of the offer.

Barclays Capital Inc. is the dealer-manager for the offer, with D.F. King & Co. Inc. as information agent.